ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Combined Hormonal Contraceptive Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-3P9630
Home | Market Reports | Health| Reproductive Health
Global Combined hormonal contraceptive Market Insights and Forecast to 2028
BUY CHAPTERS

Global Combined Hormonal Contraceptive Market Research Report 2024

Code: QYRE-Auto-3P9630
Report
April 2024
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Teva Pharmaceutical Industries
Bayer HealthCare Pharmaceuticals
Actavis
Pfizer Inc
Johnson & Johnson
GlaxoSmithKline PLC
Watson Pharma
Cipla Ltd
Novartis International

Combined Hormonal Contraceptive Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Combined Hormonal Contraceptive Market

Combined Hormonal Contraceptive Market

Combined hormonal contraceptive basically made by a combination of an estrogen and a progestogen which are primarily used to prevent unwanted pregnancies. Combined hormonal contraceptives are one of the effective contraceptives in modern medicine. Since late 1950s variety of innovation has been developed to improve the efficacy and safety of combined hormonal contraceptive. The trends have been shifted towards less androgenic progestogens and lower doses of estrogen and progestogen. Changing in drug doses and modification in drug component with the incorporation of new technologies that can reduce the risk factor and the continuing development of novel delivery systems that can be helpful to fulfill unmet needs of the market. The other health benefits of combined hormonal contraceptives include they reduce the risk of iron deficiency anemia, endometriosis, used in treating acne vulgaris, irregular menstrual flow, and polycystic ovarian syndrome. The mechanism of combined hormonal contraceptive is inhibition of follicle stimulating hormone and luteinizing hormone. Ethinylestradiol is the most common estrogen used in combined hormonal contraceptives, whereas other hormones are also used. The combined hormonal contraceptive products are available in various forms whereas pills have the maximum share in the combined hormonal contraceptive market. According to the Association of Women Health, around 100 million women use combined hormonal contraceptives throughout the world.
The global Combined Hormonal Contraceptive market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Combined Hormonal Contraceptive, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Combined Hormonal Contraceptive.

Report Scope

The Combined Hormonal Contraceptive market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Combined Hormonal Contraceptive market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Combined Hormonal Contraceptive manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Combined Hormonal Contraceptive Market Report

Report Metric Details
Report Name Combined Hormonal Contraceptive Market
CAGR 5%
Segment by Type
  • Pills
  • Patch
  • Ring
Segment by Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • E-commerce
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Teva Pharmaceutical Industries, Bayer HealthCare Pharmaceuticals, Actavis, Pfizer, Johnson & Johnson, GlaxoSmithKline, Watson Pharma, Cipla, Novartis International
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Combined Hormonal Contraceptive manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Combined Hormonal Contraceptive in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Combined Hormonal Contraceptive Market report?

Ans: The main players in the Combined Hormonal Contraceptive Market are Teva Pharmaceutical Industries, Bayer HealthCare Pharmaceuticals, Actavis, Pfizer, Johnson & Johnson, GlaxoSmithKline, Watson Pharma, Cipla, Novartis International

What are the Application segmentation covered in the Combined Hormonal Contraceptive Market report?

Ans: The Applications covered in the Combined Hormonal Contraceptive Market report are Hospital Pharmacies, Retail Pharmacies, E-commerce, Others

What are the Type segmentation covered in the Combined Hormonal Contraceptive Market report?

Ans: The Types covered in the Combined Hormonal Contraceptive Market report are Pills, Patch, Ring

1 Combined Hormonal Contraceptive Market Overview
1.1 Product Overview and Scope of Combined Hormonal Contraceptive
1.2 Combined Hormonal Contraceptive Segment by Type
1.2.1 Global Combined Hormonal Contraceptive Market Value Comparison by Type (2024-2030)
1.2.2 Pills
1.2.3 Patch
1.2.4 Ring
1.3 Combined Hormonal Contraceptive Segment by Application
1.3.1 Global Combined Hormonal Contraceptive Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 E-commerce
1.3.5 Others
1.4 Global Combined Hormonal Contraceptive Market Size Estimates and Forecasts
1.4.1 Global Combined Hormonal Contraceptive Revenue 2019-2030
1.4.2 Global Combined Hormonal Contraceptive Sales 2019-2030
1.4.3 Global Combined Hormonal Contraceptive Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Combined Hormonal Contraceptive Market Competition by Manufacturers
2.1 Global Combined Hormonal Contraceptive Sales Market Share by Manufacturers (2019-2024)
2.2 Global Combined Hormonal Contraceptive Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Combined Hormonal Contraceptive Average Price by Manufacturers (2019-2024)
2.4 Global Combined Hormonal Contraceptive Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Combined Hormonal Contraceptive, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Combined Hormonal Contraceptive, Product Type & Application
2.7 Combined Hormonal Contraceptive Market Competitive Situation and Trends
2.7.1 Combined Hormonal Contraceptive Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Combined Hormonal Contraceptive Players Market Share by Revenue
2.7.3 Global Combined Hormonal Contraceptive Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Combined Hormonal Contraceptive Retrospective Market Scenario by Region
3.1 Global Combined Hormonal Contraceptive Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Combined Hormonal Contraceptive Global Combined Hormonal Contraceptive Sales by Region: 2019-2030
3.2.1 Global Combined Hormonal Contraceptive Sales by Region: 2019-2024
3.2.2 Global Combined Hormonal Contraceptive Sales by Region: 2025-2030
3.3 Global Combined Hormonal Contraceptive Global Combined Hormonal Contraceptive Revenue by Region: 2019-2030
3.3.1 Global Combined Hormonal Contraceptive Revenue by Region: 2019-2024
3.3.2 Global Combined Hormonal Contraceptive Revenue by Region: 2025-2030
3.4 North America Combined Hormonal Contraceptive Market Facts & Figures by Country
3.4.1 North America Combined Hormonal Contraceptive Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Combined Hormonal Contraceptive Sales by Country (2019-2030)
3.4.3 North America Combined Hormonal Contraceptive Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Combined Hormonal Contraceptive Market Facts & Figures by Country
3.5.1 Europe Combined Hormonal Contraceptive Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Combined Hormonal Contraceptive Sales by Country (2019-2030)
3.5.3 Europe Combined Hormonal Contraceptive Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Combined Hormonal Contraceptive Market Facts & Figures by Country
3.6.1 Asia Pacific Combined Hormonal Contraceptive Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Combined Hormonal Contraceptive Sales by Country (2019-2030)
3.6.3 Asia Pacific Combined Hormonal Contraceptive Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Combined Hormonal Contraceptive Market Facts & Figures by Country
3.7.1 Latin America Combined Hormonal Contraceptive Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Combined Hormonal Contraceptive Sales by Country (2019-2030)
3.7.3 Latin America Combined Hormonal Contraceptive Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Combined Hormonal Contraceptive Market Facts & Figures by Country
3.8.1 Middle East and Africa Combined Hormonal Contraceptive Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Combined Hormonal Contraceptive Sales by Country (2019-2030)
3.8.3 Middle East and Africa Combined Hormonal Contraceptive Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Combined Hormonal Contraceptive Sales by Type (2019-2030)
4.1.1 Global Combined Hormonal Contraceptive Sales by Type (2019-2024)
4.1.2 Global Combined Hormonal Contraceptive Sales by Type (2025-2030)
4.1.3 Global Combined Hormonal Contraceptive Sales Market Share by Type (2019-2030)
4.2 Global Combined Hormonal Contraceptive Revenue by Type (2019-2030)
4.2.1 Global Combined Hormonal Contraceptive Revenue by Type (2019-2024)
4.2.2 Global Combined Hormonal Contraceptive Revenue by Type (2025-2030)
4.2.3 Global Combined Hormonal Contraceptive Revenue Market Share by Type (2019-2030)
4.3 Global Combined Hormonal Contraceptive Price by Type (2019-2030)
5 Segment by Application
5.1 Global Combined Hormonal Contraceptive Sales by Application (2019-2030)
5.1.1 Global Combined Hormonal Contraceptive Sales by Application (2019-2024)
5.1.2 Global Combined Hormonal Contraceptive Sales by Application (2025-2030)
5.1.3 Global Combined Hormonal Contraceptive Sales Market Share by Application (2019-2030)
5.2 Global Combined Hormonal Contraceptive Revenue by Application (2019-2030)
5.2.1 Global Combined Hormonal Contraceptive Revenue by Application (2019-2024)
5.2.2 Global Combined Hormonal Contraceptive Revenue by Application (2025-2030)
5.2.3 Global Combined Hormonal Contraceptive Revenue Market Share by Application (2019-2030)
5.3 Global Combined Hormonal Contraceptive Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Teva Pharmaceutical Industries
6.1.1 Teva Pharmaceutical Industries Corporation Information
6.1.2 Teva Pharmaceutical Industries Description and Business Overview
6.1.3 Teva Pharmaceutical Industries Combined Hormonal Contraceptive Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Teva Pharmaceutical Industries Combined Hormonal Contraceptive Product Portfolio
6.1.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.2 Bayer HealthCare Pharmaceuticals
6.2.1 Bayer HealthCare Pharmaceuticals Corporation Information
6.2.2 Bayer HealthCare Pharmaceuticals Description and Business Overview
6.2.3 Bayer HealthCare Pharmaceuticals Combined Hormonal Contraceptive Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer HealthCare Pharmaceuticals Combined Hormonal Contraceptive Product Portfolio
6.2.5 Bayer HealthCare Pharmaceuticals Recent Developments/Updates
6.3 Actavis
6.3.1 Actavis Corporation Information
6.3.2 Actavis Description and Business Overview
6.3.3 Actavis Combined Hormonal Contraceptive Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Actavis Combined Hormonal Contraceptive Product Portfolio
6.3.5 Actavis Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Combined Hormonal Contraceptive Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Combined Hormonal Contraceptive Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Combined Hormonal Contraceptive Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Johnson & Johnson Combined Hormonal Contraceptive Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Combined Hormonal Contraceptive Sales, Revenue and Gross Margin (2019-2024)
6.6.4 GlaxoSmithKline Combined Hormonal Contraceptive Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments/Updates
6.7 Watson Pharma
6.6.1 Watson Pharma Corporation Information
6.6.2 Watson Pharma Description and Business Overview
6.6.3 Watson Pharma Combined Hormonal Contraceptive Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Watson Pharma Combined Hormonal Contraceptive Product Portfolio
6.7.5 Watson Pharma Recent Developments/Updates
6.8 Cipla
6.8.1 Cipla Corporation Information
6.8.2 Cipla Description and Business Overview
6.8.3 Cipla Combined Hormonal Contraceptive Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Cipla Combined Hormonal Contraceptive Product Portfolio
6.8.5 Cipla Recent Developments/Updates
6.9 Novartis International
6.9.1 Novartis International Corporation Information
6.9.2 Novartis International Description and Business Overview
6.9.3 Novartis International Combined Hormonal Contraceptive Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Novartis International Combined Hormonal Contraceptive Product Portfolio
6.9.5 Novartis International Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Combined Hormonal Contraceptive Industry Chain Analysis
7.2 Combined Hormonal Contraceptive Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Combined Hormonal Contraceptive Production Mode & Process
7.4 Combined Hormonal Contraceptive Sales and Marketing
7.4.1 Combined Hormonal Contraceptive Sales Channels
7.4.2 Combined Hormonal Contraceptive Distributors
7.5 Combined Hormonal Contraceptive Customers
8 Combined Hormonal Contraceptive Market Dynamics
8.1 Combined Hormonal Contraceptive Industry Trends
8.2 Combined Hormonal Contraceptive Market Drivers
8.3 Combined Hormonal Contraceptive Market Challenges
8.4 Combined Hormonal Contraceptive Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Teva Pharmaceutical Industries
Bayer HealthCare Pharmaceuticals
Actavis
Pfizer Inc
Johnson & Johnson
GlaxoSmithKline PLC
Watson Pharma
Cipla Ltd
Novartis International
List of Tables
    Table 1. Global Combined Hormonal Contraceptive Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Combined Hormonal Contraceptive Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Combined Hormonal Contraceptive Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Combined Hormonal Contraceptive Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Combined Hormonal Contraceptive Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Combined Hormonal Contraceptive Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Combined Hormonal Contraceptive Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Combined Hormonal Contraceptive Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Combined Hormonal Contraceptive, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Combined Hormonal Contraceptive, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Combined Hormonal Contraceptive, Product Type & Application
    Table 12. Global Key Manufacturers of Combined Hormonal Contraceptive, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Combined Hormonal Contraceptive by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Combined Hormonal Contraceptive as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Combined Hormonal Contraceptive Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Combined Hormonal Contraceptive Sales by Region (2019-2024) & (K Units)
    Table 18. Global Combined Hormonal Contraceptive Sales Market Share by Region (2019-2024)
    Table 19. Global Combined Hormonal Contraceptive Sales by Region (2025-2030) & (K Units)
    Table 20. Global Combined Hormonal Contraceptive Sales Market Share by Region (2025-2030)
    Table 21. Global Combined Hormonal Contraceptive Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Combined Hormonal Contraceptive Revenue Market Share by Region (2019-2024)
    Table 23. Global Combined Hormonal Contraceptive Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Combined Hormonal Contraceptive Revenue Market Share by Region (2025-2030)
    Table 25. North America Combined Hormonal Contraceptive Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Combined Hormonal Contraceptive Sales by Country (2019-2024) & (K Units)
    Table 27. North America Combined Hormonal Contraceptive Sales by Country (2025-2030) & (K Units)
    Table 28. North America Combined Hormonal Contraceptive Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Combined Hormonal Contraceptive Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Combined Hormonal Contraceptive Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Combined Hormonal Contraceptive Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Combined Hormonal Contraceptive Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Combined Hormonal Contraceptive Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Combined Hormonal Contraceptive Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Combined Hormonal Contraceptive Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Combined Hormonal Contraceptive Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Combined Hormonal Contraceptive Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Combined Hormonal Contraceptive Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Combined Hormonal Contraceptive Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Combined Hormonal Contraceptive Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Combined Hormonal Contraceptive Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Combined Hormonal Contraceptive Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Combined Hormonal Contraceptive Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Combined Hormonal Contraceptive Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Combined Hormonal Contraceptive Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Combined Hormonal Contraceptive Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Combined Hormonal Contraceptive Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Combined Hormonal Contraceptive Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Combined Hormonal Contraceptive Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Combined Hormonal Contraceptive Sales (K Units) by Type (2019-2024)
    Table 51. Global Combined Hormonal Contraceptive Sales (K Units) by Type (2025-2030)
    Table 52. Global Combined Hormonal Contraceptive Sales Market Share by Type (2019-2024)
    Table 53. Global Combined Hormonal Contraceptive Sales Market Share by Type (2025-2030)
    Table 54. Global Combined Hormonal Contraceptive Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Combined Hormonal Contraceptive Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Combined Hormonal Contraceptive Revenue Market Share by Type (2019-2024)
    Table 57. Global Combined Hormonal Contraceptive Revenue Market Share by Type (2025-2030)
    Table 58. Global Combined Hormonal Contraceptive Price (USD/Unit) by Type (2019-2024)
    Table 59. Global Combined Hormonal Contraceptive Price (USD/Unit) by Type (2025-2030)
    Table 60. Global Combined Hormonal Contraceptive Sales (K Units) by Application (2019-2024)
    Table 61. Global Combined Hormonal Contraceptive Sales (K Units) by Application (2025-2030)
    Table 62. Global Combined Hormonal Contraceptive Sales Market Share by Application (2019-2024)
    Table 63. Global Combined Hormonal Contraceptive Sales Market Share by Application (2025-2030)
    Table 64. Global Combined Hormonal Contraceptive Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Combined Hormonal Contraceptive Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Combined Hormonal Contraceptive Revenue Market Share by Application (2019-2024)
    Table 67. Global Combined Hormonal Contraceptive Revenue Market Share by Application (2025-2030)
    Table 68. Global Combined Hormonal Contraceptive Price (USD/Unit) by Application (2019-2024)
    Table 69. Global Combined Hormonal Contraceptive Price (USD/Unit) by Application (2025-2030)
    Table 70. Teva Pharmaceutical Industries Corporation Information
    Table 71. Teva Pharmaceutical Industries Description and Business Overview
    Table 72. Teva Pharmaceutical Industries Combined Hormonal Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. Teva Pharmaceutical Industries Combined Hormonal Contraceptive Product
    Table 74. Teva Pharmaceutical Industries Recent Developments/Updates
    Table 75. Bayer HealthCare Pharmaceuticals Corporation Information
    Table 76. Bayer HealthCare Pharmaceuticals Description and Business Overview
    Table 77. Bayer HealthCare Pharmaceuticals Combined Hormonal Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. Bayer HealthCare Pharmaceuticals Combined Hormonal Contraceptive Product
    Table 79. Bayer HealthCare Pharmaceuticals Recent Developments/Updates
    Table 80. Actavis Corporation Information
    Table 81. Actavis Description and Business Overview
    Table 82. Actavis Combined Hormonal Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. Actavis Combined Hormonal Contraceptive Product
    Table 84. Actavis Recent Developments/Updates
    Table 85. Pfizer Corporation Information
    Table 86. Pfizer Description and Business Overview
    Table 87. Pfizer Combined Hormonal Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. Pfizer Combined Hormonal Contraceptive Product
    Table 89. Pfizer Recent Developments/Updates
    Table 90. Johnson & Johnson Corporation Information
    Table 91. Johnson & Johnson Description and Business Overview
    Table 92. Johnson & Johnson Combined Hormonal Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. Johnson & Johnson Combined Hormonal Contraceptive Product
    Table 94. Johnson & Johnson Recent Developments/Updates
    Table 95. GlaxoSmithKline Corporation Information
    Table 96. GlaxoSmithKline Description and Business Overview
    Table 97. GlaxoSmithKline Combined Hormonal Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. GlaxoSmithKline Combined Hormonal Contraceptive Product
    Table 99. GlaxoSmithKline Recent Developments/Updates
    Table 100. Watson Pharma Corporation Information
    Table 101. Watson Pharma Description and Business Overview
    Table 102. Watson Pharma Combined Hormonal Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 103. Watson Pharma Combined Hormonal Contraceptive Product
    Table 104. Watson Pharma Recent Developments/Updates
    Table 105. Cipla Corporation Information
    Table 106. Cipla Description and Business Overview
    Table 107. Cipla Combined Hormonal Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 108. Cipla Combined Hormonal Contraceptive Product
    Table 109. Cipla Recent Developments/Updates
    Table 110. Novartis International Corporation Information
    Table 111. Novartis International Description and Business Overview
    Table 112. Novartis International Combined Hormonal Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 113. Novartis International Combined Hormonal Contraceptive Product
    Table 114. Novartis International Recent Developments/Updates
    Table 115. Key Raw Materials Lists
    Table 116. Raw Materials Key Suppliers Lists
    Table 117. Combined Hormonal Contraceptive Distributors List
    Table 118. Combined Hormonal Contraceptive Customers List
    Table 119. Combined Hormonal Contraceptive Market Trends
    Table 120. Combined Hormonal Contraceptive Market Drivers
    Table 121. Combined Hormonal Contraceptive Market Challenges
    Table 122. Combined Hormonal Contraceptive Market Restraints
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Combined Hormonal Contraceptive
    Figure 2. Global Combined Hormonal Contraceptive Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Combined Hormonal Contraceptive Market Share by Type in 2023 & 2030
    Figure 4. Pills Product Picture
    Figure 5. Patch Product Picture
    Figure 6. Ring Product Picture
    Figure 7. Global Combined Hormonal Contraceptive Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Combined Hormonal Contraceptive Market Share by Application in 2023 & 2030
    Figure 9. Hospital Pharmacies
    Figure 10. Retail Pharmacies
    Figure 11. E-commerce
    Figure 12. Others
    Figure 13. Global Combined Hormonal Contraceptive Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Combined Hormonal Contraceptive Market Size (2019-2030) & (US$ Million)
    Figure 15. Global Combined Hormonal Contraceptive Sales (2019-2030) & (K Units)
    Figure 16. Global Combined Hormonal Contraceptive Average Price (USD/Unit) & (2019-2030)
    Figure 17. Combined Hormonal Contraceptive Report Years Considered
    Figure 18. Combined Hormonal Contraceptive Sales Share by Manufacturers in 2023
    Figure 19. Global Combined Hormonal Contraceptive Revenue Share by Manufacturers in 2023
    Figure 20. The Global 5 and 10 Largest Combined Hormonal Contraceptive Players: Market Share by Revenue in 2023
    Figure 21. Combined Hormonal Contraceptive Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 22. Global Combined Hormonal Contraceptive Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 23. North America Combined Hormonal Contraceptive Sales Market Share by Country (2019-2030)
    Figure 24. North America Combined Hormonal Contraceptive Revenue Market Share by Country (2019-2030)
    Figure 25. U.S. Combined Hormonal Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Canada Combined Hormonal Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Europe Combined Hormonal Contraceptive Sales Market Share by Country (2019-2030)
    Figure 28. Europe Combined Hormonal Contraceptive Revenue Market Share by Country (2019-2030)
    Figure 29. Germany Combined Hormonal Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. France Combined Hormonal Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. U.K. Combined Hormonal Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Italy Combined Hormonal Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Russia Combined Hormonal Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Combined Hormonal Contraceptive Sales Market Share by Region (2019-2030)
    Figure 35. Asia Pacific Combined Hormonal Contraceptive Revenue Market Share by Region (2019-2030)
    Figure 36. China Combined Hormonal Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Japan Combined Hormonal Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. South Korea Combined Hormonal Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. India Combined Hormonal Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Australia Combined Hormonal Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Taiwan Combined Hormonal Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Indonesia Combined Hormonal Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Thailand Combined Hormonal Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Malaysia Combined Hormonal Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Philippines Combined Hormonal Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Latin America Combined Hormonal Contraceptive Sales Market Share by Country (2019-2030)
    Figure 47. Latin America Combined Hormonal Contraceptive Revenue Market Share by Country (2019-2030)
    Figure 48. Mexico Combined Hormonal Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Brazil Combined Hormonal Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Argentina Combined Hormonal Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Middle East & Africa Combined Hormonal Contraceptive Sales Market Share by Country (2019-2030)
    Figure 52. Middle East & Africa Combined Hormonal Contraceptive Revenue Market Share by Country (2019-2030)
    Figure 53. Turkey Combined Hormonal Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Combined Hormonal Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. U.A.E Combined Hormonal Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 56. Global Sales Market Share of Combined Hormonal Contraceptive by Type (2019-2030)
    Figure 57. Global Revenue Market Share of Combined Hormonal Contraceptive by Type (2019-2030)
    Figure 58. Global Combined Hormonal Contraceptive Price (USD/Unit) by Type (2019-2030)
    Figure 59. Global Sales Market Share of Combined Hormonal Contraceptive by Application (2019-2030)
    Figure 60. Global Revenue Market Share of Combined Hormonal Contraceptive by Application (2019-2030)
    Figure 61. Global Combined Hormonal Contraceptive Price (USD/Unit) by Application (2019-2030)
    Figure 62. Combined Hormonal Contraceptive Value Chain
    Figure 63. Combined Hormonal Contraceptive Production Process
    Figure 64. Channels of Distribution (Direct Vs Distribution)
    Figure 65. Distributors Profiles
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Postpartum Rehabilitation Therapy Instruments - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-26Q13482
Thu Nov 07 00:00:00 UTC 2024

Add to Cart

Drugs for Vaginal Fungal Infections - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-27A13667
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Preeclampsia Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-39U13956
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Pregnancy & Breastfeeding Bras - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-31G13595
Mon Oct 21 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions